What is Cerdelga?
Cerdelga is the ONLY first-line oral therapy indicated for the long-term
treatment of most adults with Gaucher disease type 1.
Tamara and Nate, USA,
patients with Gaucher disease type 1 treated with Cerdelga
Cerdelga is a noninvasive oral medicine that comes in a capsule that can be taken once or twice daily.
Patients can switch to Cerdelga in as little as 24 hours after their last ERT infusion.
How Cerdelga works
Cerdelga is different from enzyme replacement therapy (ERT) infusions. Cerdelga is a noninvasive, oral medication called a substrate reduction therapy (SRT).
CERDELGA REDUCES THE AMOUNT OF GL-1 THAT IS PRODUCED
If Cerdelga is right for you, you may be able to switch from ERT 24 hours after your last infusion.